We are live on
!
Find out more
CNAM
Campbell Newman Asset Management Portfolio holdings
AUM
$1.35B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+13.35%
1 Year Est. Return
+38.87%
3 Year Est. Return
+107.92%
5 Year Est. Return
+146.05%
10 Year Est. Return
+543.08%
AUM
$648M
AUM Growth
+$72.6M
(+13%)
Cap. Flow
-$138K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
36.96%
Holding
125
New
1
Increased
65
Reduced
34
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$7.88M |
| 2 |
Boeing
BA
|
+$2.34M |
| 3 |
Merck
MRK
|
+$2.21M |
| 4 |
Eastman Chemical
EMN
|
+$704K |
| 5 |
Marathon Petroleum
MPC
|
+$669K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STI
SunTrust Banks, Inc.
STI
|
+$5.86M |
| 2 |
Apple
AAPL
|
+$5.17M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$882K |
| 4 |
Five Below
FIVE
|
+$556K |
| 5 |
Ligand Pharmaceuticals
LGND
|
+$554K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.28% |
| 2 | Healthcare | 19.63% |
| 3 | Financials | 11.61% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.16% |
Similar funds
ME
VHAM
PGH
HAM
OCMI
WTB
FFW
MC
Campbell Newman Asset Management's Q1 2019 Portfolio in Review
As of Q1 2019, Campbell Newman Asset Management held 125 positions worth $648M, up 13% from $575M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Trading was light in Q1 2019: portfolio turnover was 1.6%. Campbell Newman Asset Management opened 1 new position and exited 1, leaving the 125-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Campbell Newman Asset Management's largest Q1 2019 buy was Medifast: 4,343 shares worth $554K.
- Campbell Newman Asset Management added most to Eli Lilly in Q1 2019, an estimated $7.88M increase.
- Campbell Newman Asset Management's biggest Q1 2019 reduction was SunTrust Banks, Inc., cutting an estimated $5.86M.
- Campbell Newman Asset Management fully exited Ligand Pharmaceuticals in Q1 2019, selling an estimated $554K.
- Campbell Newman Asset Management's ten largest holdings make up 37% of its $648M portfolio in Q1 2019.
- Campbell Newman Asset Management opened 1 new position and closed 1 in Q1 2019.
- Campbell Newman Asset Management's portfolio value rose 13% quarter-over-quarter to $648M.
Based on Campbell Newman Asset Management's 13F filing for Q1 2019, filed 9 Apr 2019.